Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

315 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Milnacipran Atc N06Ax17 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7175295

EMD:Ref Document

Bid Value: Ref Document

315 Days Left

Delivery Of Medicinal Products Medicinal Products Medicinal Foods Diagnostic Agents And Other Non Therapeutic Products For The Needs Of Mobal Dr Stephan Cherkezov Jsc Veliko Tarnovo

Deadline: 15 Jul 2027

Bulgaria

Ref. No.: 7173310

EMD:Ref Document

Bid Value: Ref Document

690 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 31 Aug 2026

Germany

Ref. No.: 7169020

EMD:Ref Document

Bid Value: Ref Document

372 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Epinephrine Atc Code According To Who C01Ca24 In The Form Of A Pre Fille

Deadline: 30 Sep 2025

Germany

Ref. No.: 7168445

EMD:Ref Document

Bid Value: Ref Document

37 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 Obo For The Period From 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7166995

EMD:Ref Document

Bid Value: Ref Document

315 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 7165971

EMD:Ref Document

Bid Value: Ref Document

494 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Trientine Atc Code According To Who A16Ax12

Deadline: 30 Sep 2025

Germany

Ref. No.: 7165354

EMD:Ref Document

Bid Value: Ref Document

37 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

315 Days Left

Non Lot Allocation

Deadline: 31 Oct 2028

Germany

Ref. No.: 7161583

EMD:Ref Document

Bid Value: Ref Document

1164 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Dexamethasone Atc Code H02Ab02 That Can Be Prescribed And Dispensed As Part Of The Consultation Hou

Deadline: 27 Jun 2026

Germany

Ref. No.: 7146194

EMD:Ref Document

Bid Value: Ref Document

307 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Propofol Atc Code N01Ax10 That Can Be Prescribed And Dispensed As Part Of The Outpatient Needs In L

Deadline: 27 Jun 2026

Germany

Ref. No.: 7145649

EMD:Ref Document

Bid Value: Ref Document

307 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7139372

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lanthanum Iii Carbonate Chewable Tablets Only V03Ae03 Within The Framework Of A So

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110380

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Showing 26686 to 26700 of 27177 results

‹
1
2
...
1777
1778
1779
1780
1781
1782
1783
...
1811
1812
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!